Matches in Wikidata for { <http://www.wikidata.org/entity/Q90322139> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q90322139 description "artykuł naukowy opublikowany 14 marca 2020" @default.
- Q90322139 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q90322139 description "scientific article published on 14 March 2020" @default.
- Q90322139 description "wetenschappelijk artikel" @default.
- Q90322139 description "наукова стаття, опублікована 14 березня 2020" @default.
- Q90322139 description "գիտական հոդված հրատարակված 2020 թվականի մարտի 14-ին" @default.
- Q90322139 name "Phase 2 Study of Hyper-CMAD with Liposomal Vincristine for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia" @default.
- Q90322139 name "Phase 2 Study of Hyper-CMAD with Liposomal Vincristine for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia" @default.
- Q90322139 type Item @default.
- Q90322139 label "Phase 2 Study of Hyper-CMAD with Liposomal Vincristine for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia" @default.
- Q90322139 label "Phase 2 Study of Hyper-CMAD with Liposomal Vincristine for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia" @default.
- Q90322139 prefLabel "Phase 2 Study of Hyper-CMAD with Liposomal Vincristine for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia" @default.
- Q90322139 prefLabel "Phase 2 Study of Hyper-CMAD with Liposomal Vincristine for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia" @default.
- Q90322139 P1433 Q90322139-46C2042F-22A8-4605-BAFE-9D310F0AE10B @default.
- Q90322139 P1476 Q90322139-6A7834C1-0328-42CD-9C7D-6A5AE87B1CC1 @default.
- Q90322139 P2093 Q90322139-0B0A6DD1-E7FA-4625-BD65-D9C74425B9B0 @default.
- Q90322139 P2093 Q90322139-20E6BF4B-63FA-4A0A-BEA3-3A004E1FEF64 @default.
- Q90322139 P2093 Q90322139-DC1657D8-ECDA-4187-ADC4-D95525F565F1 @default.
- Q90322139 P2093 Q90322139-E31DCE69-4567-4C94-B77E-94254DE36D5D @default.
- Q90322139 P31 Q90322139-9B7FB120-9780-4DCC-80E8-8CAE8C2771CD @default.
- Q90322139 P356 Q90322139-9BA7F47E-276D-490C-B442-E16E8901DE3E @default.
- Q90322139 P50 Q90322139-10CBC57E-3087-4B93-8A35-3F46150ED550 @default.
- Q90322139 P50 Q90322139-129FBDDF-085C-4C04-BC2A-12E7341E1829 @default.
- Q90322139 P50 Q90322139-449AC4B2-260C-422E-8891-EE2DB0985448 @default.
- Q90322139 P50 Q90322139-946B7F4C-137B-4F39-9ABF-9E108B3CFE45 @default.
- Q90322139 P50 Q90322139-9B52F912-6385-45DD-A7F0-5A6E767E44C0 @default.
- Q90322139 P50 Q90322139-9F2AE2F9-F985-441D-A007-6F2370452B2E @default.
- Q90322139 P50 Q90322139-A5726798-98AD-437E-BC07-07CCB6647F32 @default.
- Q90322139 P50 Q90322139-B51E828E-CE7B-4D58-9A0A-1C796B05405A @default.
- Q90322139 P50 Q90322139-B53AAB02-4735-488F-B344-B238326B1BCD @default.
- Q90322139 P50 Q90322139-B5E7136A-493D-4919-A3A7-B02A81833F36 @default.
- Q90322139 P50 Q90322139-BE3ADD9F-A838-443D-A9FF-6E5673CC9828 @default.
- Q90322139 P50 Q90322139-BE90B7CD-3B51-422C-A447-73FB58635313 @default.
- Q90322139 P50 Q90322139-CDCB8189-E1C2-4DE6-9FDA-2A7AB3C5B2D6 @default.
- Q90322139 P50 Q90322139-CEF5C793-4EC7-4C37-ADD7-77B41DB29781 @default.
- Q90322139 P50 Q90322139-E71D34B8-6033-46B2-A80A-44BC9FC6F03F @default.
- Q90322139 P50 Q90322139-EDF52E6C-D85D-45D1-AE43-4532D885950F @default.
- Q90322139 P50 Q90322139-EE78AF93-F139-429B-9123-2F11CBEE5479 @default.
- Q90322139 P50 Q90322139-FD257228-7562-415C-8A8D-1E2CCC3AA489 @default.
- Q90322139 P577 Q90322139-D19453AF-39AA-4C31-9FE1-573A6CDD8A30 @default.
- Q90322139 P698 Q90322139-90268A78-A63D-41ED-92F5-8EDBA452E118 @default.
- Q90322139 P921 Q90322139-996D6EB1-FAF1-47C3-B5E0-57E3EBDAB0BA @default.
- Q90322139 P356 AJH.25784 @default.
- Q90322139 P698 32170867 @default.
- Q90322139 P1433 Q4744246 @default.
- Q90322139 P1476 "Phase 2 Study of Hyper-CMAD with Liposomal Vincristine for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia" @default.
- Q90322139 P2093 "Farhad Ravandi" @default.
- Q90322139 P2093 "Nitin Jain" @default.
- Q90322139 P2093 "Sherry Pierce" @default.
- Q90322139 P2093 "Yesid Alvarado" @default.
- Q90322139 P31 Q13442814 @default.
- Q90322139 P356 "10.1002/AJH.25784" @default.
- Q90322139 P50 Q114427906 @default.
- Q90322139 P50 Q42365103 @default.
- Q90322139 P50 Q57166181 @default.
- Q90322139 P50 Q60320900 @default.
- Q90322139 P50 Q60394812 @default.
- Q90322139 P50 Q60964369 @default.
- Q90322139 P50 Q63852514 @default.
- Q90322139 P50 Q64026278 @default.
- Q90322139 P50 Q64026337 @default.
- Q90322139 P50 Q66385413 @default.
- Q90322139 P50 Q87038533 @default.
- Q90322139 P50 Q87633434 @default.
- Q90322139 P50 Q87641766 @default.
- Q90322139 P50 Q88327648 @default.
- Q90322139 P50 Q88337925 @default.
- Q90322139 P50 Q89564940 @default.
- Q90322139 P50 Q90322123 @default.
- Q90322139 P50 Q90322134 @default.
- Q90322139 P577 "2020-03-14T00:00:00Z" @default.
- Q90322139 P698 "32170867" @default.
- Q90322139 P921 Q18553852 @default.